IMMUNOTHERAPY WITH INTERLEUKIN-2 AND SKIN CHANGES

被引：0
|
作者：
LARBRE, B
NICOLAS, JF
SARRET, Y
TOGNET, E
MERCATELLO, A
THIVOLET, J
机构：
[1] HOP EDOUARD HERRIOT,DERMATOL CLIN,PAVILLON R,PL ARSONVAL,F-69437 LYON 03,FRANCE
[2] HOP EDOUARD HERRIOT,SERV NEPHROL,F-69437 LYON 03,FRANCE
来源：
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE | 1993年 / 120卷 / 08期
关键词：
INTERLEUKIN-2; RENAL CARCINOMA; MALIGNANT MELANOMA;
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
The cutaneous manifestations which follow the administration of recombinant interleukin-2 (rIL-2) are well known, but their nature and severity have not yet been fully studied. The authors report the dermatological changes observed in 12 patients treated with rIL-2 for renal cancer. The predominant lesion was generalized erythema followed by desquamation.
引用
收藏
页码：528 / 533
页数：6
相关论文
共 50 条
  • [21] LOCAL AND REGIONAL IMMUNOTHERAPY OF CANCER WITH INTERLEUKIN-2
    BUBENIK, J
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1990, 116 (01) : 1 - 7
  • [22] INCREASE IN SOLUBLE INTERLEUKIN-2 RECEPTOR AND NEOPTERIN SERUM LEVELS DURING IMMUNOTHERAPY OF CANCER WITH INTERLEUKIN-2
    LISSONI, P
    TISI, E
    BRIVIO, F
    BARNI, S
    ROVELLI, F
    PEREGO, M
    TANCINI, G
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (08) : 1014 - 1016
  • [23] EFFECTS OF INTERLEUKIN-2 IMMUNOTHERAPY ON RENAL-FUNCTION
    KOZENY, GA
    NICOLAS, JD
    CREEKMORE, S
    STICKLIN, L
    HANO, JE
    FISHER, RI
    JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (07) : 1170 - 1176
  • [24] THROMBOCYTOPENIA DURING IMMUNOTHERAPY WITH INTERLEUKIN-2 BY CONSTANT INFUSION
    PACIUCCI, PA
    MANDELI, J
    OLEKSOWICZ, L
    AMEGLIO, F
    HOLLAND, JF
    AMERICAN JOURNAL OF MEDICINE, 1990, 89 (03): : 308 - 312
  • [25] Interleukin-2 as anticancer immunotherapy in the age of checkpoint inhibition
    Garbe, Claus
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S313 - S314
  • [26] Liposomal delivery of interleukin-2 in locoregional anticancer immunotherapy
    Storm, G
    Koppenhagen, FJ
    Steerenberg, PA
    denOtter, W
    Crommelin, DJA
    23RD INTERNATIONAL SYMPOSIUM ON CONTROLLED RELEASE OF BIOACTIVE MATERIALS, 1996 PROCEEDINGS, 1996, : 95 - 96
  • [27] Interleukin-2 and the development of immunotherapy for the treatment of patients with cancer
    Rosenberg, SA
    CANCER JOURNAL, 2000, 6 : S2 - S7
  • [28] ENHANCEMENT OF INTERLEUKIN-2 IMMUNOTHERAPY WITH L-ARGININE
    LIEBERMAN, MD
    NISHIOKA, K
    REDMOND, HP
    DALY, JM
    ANNALS OF SURGERY, 1992, 215 (02) : 157 - 165
  • [29] ADOPTIVE IMMUNOTHERAPY OF CANCER WITH ACTIVATED LYMPHOCYTES AND INTERLEUKIN-2
    KRADIN, RL
    KURNICK, JT
    PATHOLOGY AND IMMUNOPATHOLOGY RESEARCH, 1986, 5 (3-5): : 193 - 202
  • [30] Immunotherapy with interleukin-2: A study based on mathematical modeling
    Banerjee, Sandip
    INTERNATIONAL JOURNAL OF APPLIED MATHEMATICS AND COMPUTER SCIENCE, 2008, 18 (03) : 389 - 398
12345